Josie Genovese 800-737-7217
Sunnyvale, Ca (October 25, 2021) – Digitsole, a leader in the digital health space bringing together digital mobility biomarkers and biomechanical data with clinical expertise, has received Class II medical device registration with the U.S. Food and Drug Administration (FDA) for its Digitsole Pro® smart insoles. Digitsole Pro®, recently launched in the United States, is a solution, developed with, and for healthcare professionals to improve the clinical assessment of patients with mobility disorders.Read the press release
Sunnyvale, CA (January 27, 2022) – Digitsole, an industry pioneer and leader in digital health, announced today that it has officially launched its innovative second-generation, Digitsole Pro® system and smart insoles in the U.S. The next generation system will also be available to Europe and many other countries around the world.Read the press release
Please complete the contact form for all information requests about Digitsole Pro.
Our team will get back to you as soon as possible.